Embecta (EMBC) Stock Highlights

13.61 | +0.96%

2024-11-21 03:58:59

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Statistics

Range Today

13.23 13.8

Volume Today 359.3K

Range 1 Year

9.93 19.79

Volume 1 Year 106.61M

Range 3 Year

9.93 49

Volume 3 Year 414.16M

Range 10 Year

9.93 49

Volume 10 Year 414.16M

Highlights

Market Capitalization 896.69M (small)

Floating Shares 50.37M

Current Price 13.61

Price To Earnings 12.72

Price To Revenue 2.03

Earnings Per Share 1.22

Dividend Yield 3.92%

Dividend Per Share 0.6

Payout Ratio 50%

Performance

Latest +0.96%

1 Month +0.15%

3 Months -1.95%

6 Months -5.55%

1 Year -17.11%

3 Years -71.65%

5 Years -71.65%

10 Years -71.65%

Benchmarks

Market Capitalization

24 / 54

Gross Profits

9 / 39

Total Revenue

11 / 50

Total Rank

2 / 54

Free Cashflow

18 / 54

Performance 5 years

33 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.